Pro-COAG 2021

pro-COAG scientific program

Wednesday 27th of January 2021,
3:00pm -  4:20pm CET


What is pro-COAG?

Pro-COAG is a scientific and educational event, with top experts in the area of Coagulation, sharing their knowledge on current hot topics.

Since the first meeting in 2019, the pro-COAG covers topics of interest for laboratories, clinicians and healthcare institutions and facilitates a discussion to help shaping future pathways in the field of Coagulation and identifying unmet medical needs.

This year, the pro-COAG will be held virtually and we are looking forward to offering you a deep dive into Coagulation, with an exciting scientific program.


Why attend pro-COAG?

Stay up-to-date on the latest global trends and most significant developments in the area of Coagulation.

Expand your knowledge and learn from world class key opinion leaders about the latest state-of-the-art in this exciting field.

The pro-COAG meeting allows participants to exchange opinions and experience with other lab experts and clinicians around the globe.

27th of January, 2021

3:00pm - 4:20pm CET

Addressing diagnostic challenges in Coagulation during COVID-19 and beyond


15:00 – 15:05 Welcome & Introduction 
Steve Kitchen, Marcel Levi

15:05 – 15:20 Sepsis and endotheliitis: profound impact on coagulation and thrombosis 
Marcel Levi

15:20 – 15:35 Thrombosis, Cancer and COVID-19
Anna Falanga

15:35 – 15:50 Vitamin K deficiency as the potential missing link between lung damage and thromboembolism in COVID-19
Rob Janssen

15:50 – 16:05 Anticoagulation for the prevention of COVID-19-associated thrombosis
Adam Cuker

16:05 – 16:15 Questions & Answers
All Speakers

16:15 – 16:20 Closing
Steve Kitchen, Marcel Levi

Steve Kitchen

Steve Kitchen



Steve Kitchen is lead scientist at the coagulation laboratory of the Sheffield Haemophilia and Thrombosis Centre, which is part of the Sheffield teaching hospitals and designated as an International Haemophilia Training Centre by the World Federation of Haemophilia. In addition, he is the Scientific Director of the UK National External Quality Assessment Scheme for Blood Coagulation and Director of the WFH International External Quality Assessment Schemes for Blood Coagulation. Steve is also on the Steering committee UK NEQAS Blood Coagulation, part of the World Federation of Haemophilia, SSC Working Group on Diagnostic Standards and vice chair for Haemostasis at the ICSH.

Marcel Levi

Prof. Marcel Levi



Marcel Levi is Professor of Medicine at University College London Hospitals UCL and a practicing physician in Acute Medicine and Haematology. Previously he was Dean of the Faculty of Medicine of the University of Amsterdam and Chief Executive of the Academic Medical Center in Amsterdam. He has published more than 700 articles in scientific journals and has been awarded a number of international research awards. He was chairman of the Netherlands Organization for Health Research and is currently chairman of the scientific board of several national charities, including the Dutch Heart Foundation, and a board member of the National Cancer Institute. He is a member of the Royal Netherlands Academy of Science and Fellow of the Royal College of Physicians.

Anna Falanga

Anna Falanga

MD, Professor of Hematology


Anna Falanga, MD, is full professor of Hematology at University of Milan Bicocca and Chief of the Department of Immunohematology and Transfusion Medicine and the Thrombosis and Hemostasis Center, at the Hospital Papa Giovanni XXIII, in Bergamo, Italy. She has authored more than 300 publications and is guest editor of 21 volumes. She is an expert in the field of cancer and thrombosis. She has an active role in several professional societies, including the International Society of Thrombosis and Haemostasis (ISTH), the European Hematology Association (EHA), the Italian Society of Thrombosis and Hemostasis (SISET). She received the BACH Investigator Award of the ISTH (2009), and the “Harold R. Roberts Medal 2015” of the SSC of ISTH (2015).

Rob Janssen

Dr. Rob Janssen



Rob Janssen is a pulmonologist in the Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands since 2008. He was trained as a pulmonologist in the St Antonius Hospital, Nieuwegein, The Netherlands and studied medicine in Utrecht, The Netherlands. He is a translational pulmonary researcher with a focus on elastic fiber metabolism in lung emphysema and fibrosis. He switched focus to COVID-19 research and was the first to demonstrate severe extrahepatic vitamin K deficiency in COVID‑19.

Adam Cuker

Adam Cuker



Adam Cuker is Associate Professor of Medicine and Pathology & Laboratory Medicine at the University of Pennsylvania. He received his M.D. from Yale University and completed an internship and residency in internal medicine at Brigham and Women’s Hospital and Harvard Medical School. He continued his postgraduate training at the Hospital of the University of Pennsylvania where he was a fellow in hematology/oncology. He holds a Masters degree in Translational Research from the University of Pennsylvania. He is Director of the Penn Comprehensive Hemophilia & Thrombosis Program, Assistant Director of the Penn Specialized Coagulation Laboratory, and Associate Director of the Penn-CHOP Blood Center for Patient Care and Discovery. He conducts patient-oriented research on disorders of hemostasis and thrombosis. He is Chair of the American Society of Hematology Guidelines on COVID-19 and anticoagulation.

Related information